FIELD: medicine.
SUBSTANCE: invention belongs to medicine, notably to pharmacology, and relates to applications of 2-(3,4-dihydroxyphenyl)-9-diethylaminoethylimidazo[1,2-a]benzimidazole dihydrobromide within manufacture of medication, possessing anti-ischemic, hemoreologic and anti-radical properties, and to pharmaceutical composition, possessing above mentioned properties.
EFFECT: agent possesses high activity and doesn't have intense side effects.
10 cl, 1 dwg, 18 tbl
Title | Year | Author | Number |
---|---|---|---|
MEDICATION WHICH POSSESSES ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2440814C1 |
AGENT POSSESSING ANTIARRHYTHMIC AND HEPATOPROTECTIVE PROPERTIES | 2011 |
|
RU2469720C1 |
DRUG POSSESSING ANTIHYPOXIC, ACTOPROTECTIVE, NOOTROPIC ACTIVITIES AND HAVING EFFECT ON PHYSICAL EFFICIENCY, AND BASED PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2462245C1 |
AGENT POSSESSING ANTIRADICAL, CEREBROPROTECTIVE AND ANTIISCHEMIC PROPERTIES | 2010 |
|
RU2445090C1 |
AGENT HAVING CARDIOPROTECTIVE ACTION AND 1,3-DISUBSTITUTED 2-AMINOBENZIMIDAZOLIUM HALIDES | 2013 |
|
RU2526902C1 |
CORRECTOR FOR HAEMORHEOLOGICAL DISTURBANCES IN CONDITIONS COMPLICATED WITH BLOOD HYPERVISCOSITY SYNDROME | 2009 |
|
RU2406500C1 |
9-SUBSTITUTED 2-HALOGENPHENYLIMIDAZO[1,2-a]BENZIMIDAZOLE SALTS AND 1-SUBSTITUTED 3-HALOGENPHENACYL-2-AMINOBENZIMIDAZOLIUM HALIDES POSSESSING HEMORHEOLOGICAL PROPERTIES | 2005 |
|
RU2290404C1 |
AGENT SHOWING ANTIAGGREGANT AND ANTITHROMBOGENIC ACTIVITY | 2010 |
|
RU2453312C1 |
1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
ANTITHROMBOTIC AGENT AFFECTING REGULATION OF THROMBOCYTE CAPACITY | 2008 |
|
RU2377990C1 |
Authors
Dates
2010-06-20—Published
2008-05-12—Filed